Inloggad som:
HER2-Ex-PET
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
Her2
HER2-Ex-PET
A multicentre, prospective, open-label study to with [68Ga]Ga-ABY-025 PET-imaging to characterize HER2-expression and explore the therapy-predictive value for HER2-antibody drug conjugates in patients with metastatic breast cancer.
A multicentre, prospective, open-label study to with [68Ga]Ga-ABY-025 PET-imaging to characterize HER2-expression and explore the therapy-predictive value for HER2-antibody drug conjugates in patients with metastatic breast cancer.
PLACEHOLDER
Mer information om studien för vårdgivare
Studien ändrades senast av: studyjohanna (2025-06-16)